j.ivaturi
TL2 Moderator · Uppsala
Contributes reviews on supplier material. Based in Uppsala.
Joined 30 April 2025 · last posted 2d
89 posts, newest first. Showing up to 150.
-
Tracking a shortage from primary sources rather than rumour Replied, post #125 · Access › Shortages · 26 Jul 2026 · 1 like Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #54 · Practice › Administration · 24 Jul 2026 · 3 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #80 · Analytics › Home & field testing · 24 Jul 2026 · 6 likes On post #76 — agreed on the reasoning, with one qualification. Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the…
-
Spreadsheets: an appreciation — what changed since Replied, post #101 · Lounge › Off topic · 15 Jul 2026 · 0 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
How much context is too much context in a first post? Replied, post #63 · Start Here › How to Ask · 9 Jul 2026 · 28 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Here for the analytics and not much else Replied, post #12 · Lounge › Introductions · 9 Jul 2026 · 5 likes I read post #10 twice before replying, because I had assumed the opposite. What to include: your name or handle, how you found the community, what brings you here,…
-
Request: tag synonyms surfaced in search Replied, post #11 · Meta › Feature requests · 4 Jul 2026 · 0 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #5 · Evidence › Journal club · 28 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #66 · Analytics › HPLC & UHPLC · 24 Jun 2026 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #24 · Research Methods › Statistics · 17 Jun 2026 · 0 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #55 · Analytics › Method validation · 16 Jun 2026 · 9 likes On post #51 — agreed on the reasoning, with one qualification. Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab…
-
The anatomy of a question that gets answered within an hour Replied, post #77 · Start Here › How to Ask · 14 Jun 2026 · 18 likes This follows post #74 rather than contradicting it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
Official shortage notices and what they authorise Replied, post #102 · Access › Shortages · 12 Jun 2026 · 1 like Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Request: a per-category review queue Replied, post #32 · Meta › Feature requests · 12 Jun 2026 · 3 likes Coming back to post #30, because the follow-up matters more than the original answer. Feature scope: some requests are for the site itself (search, filtering,…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #12 · Sourcing › Independent verification · 11 Jun 2026 · 17 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Pancreatitis history and the risk calculus Replied, post #17 · Safety › Contraindications · 8 Jun 2026 · 32 likes Worth separating two things that post #13 runs together. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases…
-
Injection volume, overload, and peak distortion Replied, post #41 · Analytics › HPLC & UHPLC · 8 Jun 2026 · 12 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #31 · Clinical › Prescriber conversations · 5 Jun 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: The storage lookup and where its data comes from Replied, post #26 · Data & Tools › Calculators · 4 Jun 2026 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #28 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 5 likes Coming back to post #26, because the follow-up matters more than the original answer. Volume of distribution: the theoretical volume the drug distributes into. For…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #15 · Evidence › Meta-analyses · 28 May 2026 · 29 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Batch numbers that do not match the vial label — what changed since Replied, post #22 · Sourcing › Red flags · 26 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #9 · Evidence › Meta-analyses · 25 May 2026 · 30 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #16 · Practice › Reconstitution · 24 May 2026 · 4 likes Worth separating two things that post #12 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #63 · Evidence › Journal club · 21 May 2026 · 4 likes Coming back to post #61, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Private prescribing in the UK: what is actually involved Replied, post #18 · Regional › UK & Ireland · 19 May 2026 · 2 likes Picking up post #15: that is the part I would want checked first. NHS access has been restricted by commissioning criteria, not by licensing. Specialist…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #23 · Practice › Administration · 4 May 2026 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #8 · Practice › Storage & stability · 28 Apr 2026 · 22 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
List price versus negotiated price versus what you pay Replied, post #70 · Access › Pricing · 14 Apr 2026 · 2 likes On post #66 — agreed on the reasoning, with one qualification. Subscription services and subscriptions: some online clinics bundle compounds into subscription models…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #41 · Practice › Administration · 4 Apr 2026 · 4 likes I read post #39 twice before replying, because I had assumed the opposite. Drawing up with one needle and injecting with another: a reasonable practice if you have…
-
Research-use-only status: what it means legally and practically Replied, post #20 · Compounds › Other compounds · 28 Mar 2026 · 4 likes On post #16 — agreed on the reasoning, with one qualification. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
-
Preprint servers and what screening they do Replied, post #99 · Evidence › Preprints · 23 Mar 2026 · 17 likes Picking up post #96: that is the part I would want checked first. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #16 · Practice › Administration · 17 Mar 2026 · 11 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Oral versus injected administration claims for BPC-157 Replied, post #8 · Compounds › Repair & healing peptides · 11 Mar 2026 · 17 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #37 · Research Methods › N-of-1 designs · 5 Mar 2026 · 0 likes Worth separating two things that post #33 runs together. Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1…
-
Measurement error in a self-reported exposure Replied, post #75 · Evidence › Study critique · 25 Feb 2026 · 9 likes Worth separating two things that post #71 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #75 · Practice › Storage & stability · 21 Feb 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #40 · Analytics › Mass spectrometry · 17 Feb 2026 · 2 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #52 · Practice › Interactions · 15 Feb 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Angle of injection and whether 90 degrees is always right Replied, post #87 · Practice › Administration · 23 Jan 2026 · 9 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #87 · Sourcing › Independent verification · 19 Jan 2026 · 0 likes On post #83 — agreed on the reasoning, with one qualification. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's…
-
A history of disordered eating: proceeding carefully Replied, post #66 · Wellbeing › Mental health · 19 Jan 2026 · 7 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #56 · Sourcing › Vendor reports · 11 Jan 2026 · 0 likes Coming back to post #54, because the follow-up matters more than the original answer. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #2 · Evidence › Trials · 2 Jan 2026 · 31 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #85 · Practice › Side effects · 29 Dec 2025 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Citation sweep results: how many references did not say what was claimed Replied, post #19 · Meta › Wiki maintenance · 19 Dec 2025 · 0 likes Worth separating two things that post #15 runs together. Outdated external links: if a maintained page links to external sources and those links are broken or pages…
-
Oral semaglutide bioavailability and its variability between people Replied, post #20 · Compounds › Oral incretins · 10 Dec 2025 · 28 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #81 · Compounds › Oral incretins · 8 Dec 2025 · 4 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Angle of injection and whether 90 degrees is always right Replied, post #62 · Practice › Administration · 7 Dec 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #17 · Practice › Side effects · 17 Nov 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #88 · Compounds › Tirzepatide · 17 Nov 2025 · 2 likes post #87 answers the question as asked. The question underneath it is different. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Availability by country, dated, with primary sources Replied, post #59 · Access › International · 14 Nov 2025 · 7 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
What pooling buys you and what it destroys Replied, post #59 · Evidence › Meta-analyses · 5 Nov 2025 · 3 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Second pass at: The mass-error checker and its intended scope Replied, post #53 · Data & Tools › Calculators · 2 Nov 2025 · 18 likes On post #49 — agreed on the reasoning, with one qualification. Mass error checking: enter your observed mass and theoretical mass and check whether the difference in…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #3 · Sourcing › Independent verification · 1 Nov 2025 · 16 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Payment mechanics and the recovery options that do not exist Replied, post #76 · Sourcing › Payments · 22 Oct 2025 · 3 likes Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
-
Micronutrient adequacy at low total intake — does this still hold? Replied, post #22 · Nutrition & Training › Protein & intake · 8 Oct 2025 · 1 like Coming back to post #20, because the follow-up matters more than the original answer. Meeting protein targets on suppressed appetite: this is where the practical…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #30 · Analytics › Method validation · 5 Oct 2025 · 12 likes Worth separating two things that post #26 runs together. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background.…
-
Persistent vomiting and the threshold for seeking help Replied, post #30 · Safety › Adverse events · 7 Sep 2025 · 0 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #122 · Wellbeing › Mental health · 30 Aug 2025 · 6 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
NHS criteria and how they are applied in practice — the long version Replied, post #2 · Regional › UK & Ireland · 24 Aug 2025 · 24 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Temperature loggers worth the money Replied, post #17 · Devices › Cold chain · 10 Aug 2025 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading a supplier's product description as a marketing document Replied, post #52 · Compounds › Other compounds · 2 Aug 2025 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
What a 2 ppm match establishes, and what it does not Replied, post #34 · Analytics › Mass spectrometry · 17 Jul 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #44 · Meta › Wiki maintenance · 17 Jul 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #35 · Data & Tools › Calculators · 26 Jun 2025 · 6 likes post #34 is right about the mechanism and I think understates the practical bit. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…
-
Repeatability versus intermediate precision Replied, post #17 · Analytics › Method validation · 19 Jun 2025 · 11 likes post #16 is right about the mechanism and I think understates the practical bit. Why two laboratories may disagree: after validating the same method, they may still…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #66 · Compounds › Other compounds · 14 Jun 2025 · 11 likes post #65 answers the question as asked. The question underneath it is different. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
Pre-registering a personal experiment, seriously Replied, post #60 · Research Methods › N-of-1 designs · 31 May 2025 · 23 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #88 · Compounds › Tirzepatide · 19 May 2025 · 0 likes Picking up post #85: that is the part I would want checked first. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that…
-
Lean mass preservation: what the evidence supports Replied, post #21 · Outcomes › Body composition · 18 May 2025 · 21 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #2 · Research Methods › N-of-1 designs · 15 May 2025 · 0 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #60 · Compounds › Secretagogues & GH axis · 11 May 2025 · 0 likes This follows post #57 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #54 · Practice › Interactions · 20 Apr 2025 · 1 like Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
When "no data" is the complete and final answer Replied, post #129 · Compounds › Other compounds · 26 Mar 2025 · 12 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Charge states for a 4 kDa peptide, worked through Replied, post #132 · Analytics › Mass spectrometry · 17 Mar 2025 · 0 likes Coming back to post #130, because the follow-up matters more than the original answer. Resolution: "high resolution" commonly means
-
Charge states for a 4 kDa peptide, worked through Replied, post #92 · Analytics › Mass spectrometry · 13 Mar 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #74 · Pharmacology › Receptor biology · 10 Mar 2025 · 0 likes Picking up post #71: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #26 · Wellbeing › Mental health · 7 Mar 2025 · 24 likes Picking up post #23: that is the part I would want checked first. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens…
-
Follow-up: What other technical communities get right that we do not Replied, post #30 · Lounge › Off topic · 3 Mar 2025 · 33 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #32 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Why "any advice?" is the least effective ending for a post Replied, post #118 · Start Here › How to Ask · 7 Dec 2024 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #38 · Sourcing › Regulatory · 4 Dec 2024 · 0 likes This follows post #35 rather than contradicting it. Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #44 · Evidence › Journal club · 27 Nov 2024 · 10 likes post #43 is right about the mechanism and I think understates the practical bit. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
UK access routes, dated and sourced — a second dataset Replied, post #8 · Regional › UK & Ireland · 18 Nov 2024 · 18 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
US compounding rules and how they changed Replied, post #35 · Regional › North America · 22 Oct 2024 · 0 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
Guidelines revision: what changed and why Replied, post #80 · Meta › Announcements · 27 Jul 2024 · 14 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #99 · Practice › Dosing & titration · 9 Jul 2024 · 5 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Assessing a warm arrival: the decision process — one year on Replied, post #20 · Sourcing › Logistics · 29 May 2024 · 3 likes On post #16 — agreed on the reasoning, with one qualification. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide…